ConductScience.org, home

Trial · NCT02173379

Outcomes169

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Target Lesion Failure (TLF)30 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTLF at 1-year, Non-inferiority Against the Control1 yearITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYAngina at 1-year, Non-inferiority Against the Control1 yearITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPercentage of Target Lesion With Acute Success- Device Success (Lesion Level Analysis)In-hospital (≤ 7days)ITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.Percentage of target lesionsNUMBER
SECONDARYNumber of Participants With Acute Success- Procedural Success (Subject Level Analysis)In-hospital (≤ 7days)ITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)In-hospital (≤ 7 days post index procedure)ITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)30 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)90 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)180 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)270 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)1 yearITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)2 yearsITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)3 yearsITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)4 yearsITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Death (Cardiac, Vascular, Non-cardiovascular)5 yearsITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Myocardial Infarction (MI)In-hospital (≤ 7 days post index procedure)ITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Myocardial Infarction (MI)30 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Myocardial Infarction (MI)90 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Myocardial Infarction (MI)180 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Myocardial Infarction (MI)270 daysITT population.The number of participants analyzed includes subjects who had available follow up data at that time frame.ParticipantsCOUNT_OF_PARTICIPANTS

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02173379/outcomes